Brief: Genovis Q1 Revenue Rises By 119%
16/05/2023 07:12
May 16 (Reuters) - Genovis AB GENOb.ST :
* GENOVIS AB - Q1 OPERATING PROFIT BEFORE DEPRECIATION AND
AMORTIZATION (EBITDA) TOTALED SEK 45,089 (11,717) THOUSAND
* Q1 NET SALES TOTALED SEK 71,276 (32,574) THOUSAND
* STARTED Q1 OF YEAR WITH RECORD-BREAKING SALES
* REVENUE INCREASED BY 119%, DRIVEN BY GENE THERAPY LICENSE
REVENUE, AND AT SAME TIME WE DELIVERED OUR BEST QUARTER EVER FOR
CORE BUSINESS
Source text for Eikon: ID:nWkr44CqFv
Further company coverage: GENOb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))